Search Results
Life Science Today 100 – Pfizer + Biohaven, Regulators, Lilly, BridgeBio + BMS
Life Science Today 093 - 2seventy Bio, Ascendis, Apellis, Argenx
BridgeBio Plunges After Acoramidis Study Fails to Meet Primary Endpoint
A message from our chief scientific officer, Philip Gregory, D. Phil
A message from our chief kairos officer, Nick Leschly
BridgeBio (BBIO) Tumbled - Should I Buy?
How dilution can crush biotech returns
